BIG Clinical Trials

Open
In development
In follow up
Closed

Open trials
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

BIG 2-02 SOFT / IBCSG 24-02
BIG 3-02 TEXT / IBCSG 25-02
BIG 5-02 IBIS-II / IBCSG 31-03
BIG 1-03 REACT / GBG 27 / ICCG C-20-01
BIG 2-03 Breast cancer in pregnancy / GBG 29
BIG 2-04 SUPREMO / MREC 05-S0501-106
BIG 3-04 MINDACT / EORTC 10041
BIG 2-06 ALTTO / N063D / EGF 106708
BIG 1-07 SOLE / IBCSG 35-07
BIG 3-07 DCIS / TROG 07.01
BIG 1-010 SOLD / FBCG

Trials in development
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

BIG 2-07 Male Breast Cancer

_top

Trials in follow up
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

BIG 1-97 / NCIC CGT MA.17
BIG 2-97 IES / C-13 96
BIG 3-97 HABITS
BIG 1-98 / IBCSG 18-98
BIG 2-98 TAX 315
BIG 1-00 p53 / EORTC 10994
BIG 1-01 HERA / BO 16348
BIG 1-02 Loco-regional relapse / IBCSG 27-02 / NSABP B-37
BIG 4-02 PERCHE / IBCSG 26-02
BIG 1-04 AZURE
BIG 4-04 ICE / GBG 32
BIG 1-05 CASA / IBCSG 32-05
BIG 2-05 ACTION
BIG 3-05 TBP / GBG 26
BIG 1-06 Neo-ALTTO / EGF 106903

_top

Closed trials
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

BIG 3-98 Young Patients / EORTC 10002
BIG 4-98 PEAT / EORTC 10963
BIG 2-00 Lamanoma / EORTC 10974

 _top